These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28790173)

  • 1. Hu antigen R (HuR) multimerization contributes to glioma disease progression.
    Filippova N; Yang X; Ananthan S; Sorochinsky A; Hackney JR; Gentry Z; Bae S; King P; Nabors LB
    J Biol Chem; 2017 Oct; 292(41):16999-17010. PubMed ID: 28790173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression.
    Luo C; Chen G; Li R; Peng S; Zhang P; Wang F; Yu S; Zhu Y; Zhang J
    Biochem Pharmacol; 2024 Sep; 227():116458. PubMed ID: 39102993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA SNHG12promotes the proliferation and migration of glioma cells by binding to HuR.
    Lei W; Wang ZL; Feng HJ; Lin XD; Li CZ; Fan D
    Int J Oncol; 2018 Sep; 53(3):1374-1384. PubMed ID: 30015836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNA-binding protein HuR promotes glioma growth and treatment resistance.
    Filippova N; Yang X; Wang Y; Gillespie GY; Langford C; King PH; Wheeler C; Nabors LB
    Mol Cancer Res; 2011 May; 9(5):648-59. PubMed ID: 21498545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cancer effects of the HuR inhibitor, MS-444, in malignant glioma cells.
    Wang J; Hjelmeland AB; Nabors LB; King PH
    Cancer Biol Ther; 2019; 20(7):979-988. PubMed ID: 30991885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-145 suppresses gastric cancer progression by targeting Hu-antigen R.
    Li Q; Tong D; Guo C; Wu F; Li F; Wang X; Jiang Q; Wei Y; Liu L; Ni L; Guo B; Huang C
    Am J Physiol Cell Physiol; 2020 Mar; 318(3):C605-C614. PubMed ID: 31940247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia.
    Gauchotte G; Hergalant S; Vigouroux C; Casse JM; Houlgatte R; Kaoma T; Helle D; Brochin L; Rech F; Peyre M; Labrousse F; Vallar L; Guéant JL; Vignaud JM; Battaglia-Hsu SF
    J Pathol; 2017 Aug; 242(4):421-434. PubMed ID: 28493484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of translocator protein 18 kDa suppressed the progression of glioma via the ELAV-like RNA-binding protein 1/MAPK-activated protein kinase 3 axis.
    Wang J; Ren P; Zeng Z; Ma L; Li Y; Zhang H; Guo W
    Bioengineered; 2022 Mar; 13(3):7457-7470. PubMed ID: 35285415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis.
    Wu X; Gardashova G; Lan L; Han S; Zhong C; Marquez RT; Wei L; Wood S; Roy S; Gowthaman R; Karanicolas J; Gao FP; Dixon DA; Welch DR; Li L; Ji M; Aubé J; Xu L
    Commun Biol; 2020 Apr; 3(1):193. PubMed ID: 32332873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer.
    Liu Y; Chen X; Cheng R; Yang F; Yu M; Wang C; Cui S; Hong Y; Liang H; Liu M; Zhao C; Ding M; Sun W; Liu Z; Sun F; Zhang C; Zhou Z; Jiang X; Chen X
    Mol Cancer; 2018 Jan; 17(1):11. PubMed ID: 29351796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of HuR structure and function by dihydrotanshinone-I.
    Lal P; Cerofolini L; D'Agostino VG; Zucal C; Fuccio C; Bonomo I; Dassi E; Giuntini S; Di Maio D; Vishwakarma V; Preet R; Williams SN; Fairlamb MS; Munk R; Lehrmann E; Abdelmohsen K; Elezgarai SR; Luchinat C; Novellino E; Quattrone A; Biasini E; Manzoni L; Gorospe M; Dixon DA; Seneci P; Marinelli L; Fragai M; Provenzani A
    Nucleic Acids Res; 2017 Sep; 45(16):9514-9527. PubMed ID: 28934484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
    Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
    Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells.
    Tan S; Ding K; Chong QY; Zhao J; Liu Y; Shao Y; Zhang Y; Yu Q; Xiong Z; Zhang W; Zhang M; Li G; Li X; Kong X; Ahmad A; Wu Z; Wu Q; Zhao X; Lobie PE; Zhu T
    J Biol Chem; 2017 Aug; 292(33):13551-13564. PubMed ID: 28637868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors.
    Filippova N; Yang X; Ananthan S; Calano J; Pathak V; Bratton L; Vekariya RH; Zhang S; Ofori E; Hayward EN; Namkoong D; Crossman DK; Crowley MR; King PH; Mobley J; Nabors LB
    Cancer Res; 2021 Apr; 81(8):2220-2233. PubMed ID: 33602784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment.
    Kotta-Loizou I; Vasilopoulos SN; Coutts RH; Theocharis S
    Neoplasia; 2016 Nov; 18(11):674-688. PubMed ID: 27764700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function.
    D'Agostino VG; Lal P; Mantelli B; Tiedje C; Zucal C; Thongon N; Gaestel M; Latorre E; Marinelli L; Seneci P; Amadio M; Provenzani A
    Sci Rep; 2015 Nov; 5():16478. PubMed ID: 26553968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.
    Muralidharan R; Mehta M; Ahmed R; Roy S; Xu L; Aubé J; Chen A; Zhao YD; Herman T; Ramesh R; Munshi A
    Sci Rep; 2017 Aug; 7(1):9694. PubMed ID: 28855578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis.
    Palomo-Irigoyen M; Pérez-Andrés E; Iruarrizaga-Lejarreta M; Barreira-Manrique A; Tamayo-Caro M; Vila-Vecilla L; Moreno-Cugnon L; Beitia N; Medrano D; Fernández-Ramos D; Lozano JJ; Okawa S; Lavín JL; Martín-Martín N; Sutherland JD; de Juan VG; Gonzalez-Lopez M; Macías-Cámara N; Mosén-Ansorena D; Laraba L; Hanemann CO; Ercolano E; Parkinson DB; Schultz CW; Araúzo-Bravo MJ; Ascensión AM; Gerovska D; Iribar H; Izeta A; Pytel P; Krastel P; Provenzani A; Seneci P; Carrasco RD; Del Sol A; Martinez-Chantar ML; Barrio R; Serra E; Lazaro C; Flanagan AM; Gorospe M; Ratner N; Aransay AM; Carracedo A; Varela-Rey M; Woodhoo A
    J Clin Invest; 2020 Jul; 130(7):3848-3864. PubMed ID: 32315290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
    Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
    Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin Expression Is Regulated at the Post-transcriptional Level by the RNA-binding Proteins HuR and AUF1.
    Sun S; Zhang X; Lyu L; Li X; Yao S; Zhang J
    J Biol Chem; 2016 Dec; 291(50):25823-25836. PubMed ID: 27784781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.